Renal Cell Carcinoma (RCC)
Conditions
Interventions
Patients group:Not Applicable
Doctors group:Not Applicable
Sponsors
Fudan University Shanghai Cancer Center
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All inclusion and exclusion criteria will be reviewed by the investigator or qualified designee to ensure that the subject qualifies for the study. Respondents must meet all of the following inclusion criteria to be eligible for inclusion in the patient survey study: 1. Patient is aged 18 years or older 2. Patient is a resident with Chinese nationality 3. Patient is able to read and understand simplified Chinese 4. Patient can provide informed consent 5. Patient has physician-confirmed diagnosis of resectable stage ?-? RCC. 6. Patient has either undergone nephrectomy (partial/radical) = 36 months ago or with no prior nephrectomy but has a scheduled/physician-confirmed high-probability nephrectomy planned within the next 6 months. Respondents must meet all of the following inclusion criteria to be eligible for inclusion in the physician survey study: 1. Urologist is a resident with Chinese nationality 2. Urologist is able to read and understand simplified Chinese 3. Urologist can provide informed consent 4. Urologist is an attending physician with more than 3-year experience, or above 5. Urologist involves in management of at least 15 resectable RCC in past 12 months
Exclusion criteria
Exclusion criteria: Patients with stage ? RCC and those with metastatic stage ? disease (M1) will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Preference weights for each attribute level;Conditional relative importance (CRI);Maximum acceptable risk (MAR);EQ-5D score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of patients aware of RCC recurrence risk concept;Physician awareness of recurrence risk stratification;Current treatment pattern for early RCC patients after nephrectomy;NFKSI-19 score; | — |
Countries
China
Contacts
Public ContactYe Dingwei
Fudan University Shanghai Cancer Center
Outcome results
None listed